Nom du produit:4-(3-Bromopropyl)-3,5-dimethyl-1H-pyrazole
IUPAC Name:4-(3-bromopropyl)-3,5-dimethyl-1H-pyrazole
- CAS：2167368-32-1
- Formule moléculaire：C8H13BrN2
- Pureté：95%
- Numéro de catalogue：CM1075073
- Poids moléculaire：217.11
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2167368-32-1
- Formule moléculaire:C8H13BrN2
- Point de fusion:-
- Code SMILES:CC1=C(CCCBr)C(C)=NN1
- Densité:
- Numéro de catalogue:CM1075073
- Poids moléculaire:217.11
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- Acoramidis
- In 2023, BridgeBio announced positive results from ATTRibute-CM, a Phase 3 study of acoramidis in ATTR cardiomyopathy (ATTR-CM). For patients with ATTR-CM, TTR stabilization offers the chance to both preserve the cardio-protective benefits of TTR and address the root cause of disease. Acoramidis (AG10) is an investigational, next-generation, orally-administered, highly potent, small molecule stabilizer of transthyretin (TTR).
Recherche 
+86 21 5895 0110 
